Clinical Trials · NCT01434862
Pramlintide Combined With Model Predictive Control Algorithm
- Phase
- N/A
- Recruitment status
- Terminated
- Sponsor
- University of Virginia
- Enrollment
- 2
- Start date
- Feb 2011
- Locations
- 1 site, United States
- Primary endpoint
- Percent of Blood glucose tests within target range of 70 to 180 mg/dl